جست‌وجوی استاد و پژوهشگر

Sophia Banoمشاهده پروفایل

استادیار

• Computer Vision
• Surgical Robotics
• Medical Imaging
• +۳ مورد دیگر

Sophia Bano is an Assistant Professor in Robotics and Artificial Intelligence at the Department of Computer Science, University College London (UCL), since November 2022. She is affiliated with the Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS), Surgical Robot Vision group, UCL Robotics Institute, and the Centre for Artificial Intelligence. Previously, she was a Senior Research Fellow at WEISS, contributing to the GIFT-Surg project. Her research focuses on AI-driven techniques for context awareness, navigation, and surgical robotics in minimally invasive procedures, including endoscopic workflow analysis, 3D reconstruction, and surgical vision systems. Education: BEng in Mechatronics Engineering (NUST, Pakistan), MSc in Electrical Engineering (NUST), MSc in Computer Vision and Robotics (Erasmus Mundus VIBOT), PhD from Queen Mary University of London and Technical University of Catalonia (Erasmus Mundus Fellowship). Post-doctoral work at University of Dundee (EPSRC ACE-LP project) and Imperial College London (ERC STING project). Research interests include computer vision for surgery, medical imaging, surgical robotics, and AI in healthcare. She leads the UKRI EPSRC-funded 'AI-enabled Decision Support in Pituitary Surgery' project and contributed to the GIFT-Surg and CARES projects. Publications span 3D reconstruction in fetoscopy, surgical workflow recognition, and AI models for medical imaging. Awards include the IJCARS-MICCAI Best Paper Award (2020) and the Best Innovation Award at the 2022 Surgical Robot Challenge. She organizes conferences like EndoVis and serves as a reviewer for journals like IEEE Transactions on Medical Imaging and MICCAI.

• Computational Chemistry
• Computer-Aided Drug Design
• Cheminformatics
• +۱۲ مورد دیگر

Andrea Volkamer is a computational chemist and active principal investigator in the field of computer-aided drug design (CADD), with a focus on kinase targets, druggability prediction, and machine learning applications. She has published extensively in journals such as the Journal of Chemical Information and Modeling and Journal of Medicinal Chemistry , with recent work up to 2025 indicating an ongoing academic research program. Her research group, referred to as 'volkamerlab,' develops open-source tools including DoGSite, KiSSim, KinFragLib, and TeachOpenCADD, which are widely used in both academic and industrial drug discovery settings. Her research interests span computational drug discovery , structural bioinformatics , kinase inhibitor design , off-target and polypharmacology prediction , and educational platforms for CADD . She emphasizes open science and reproducibility, particularly through the TeachOpenCADD initiative, which provides interactive Jupyter Notebooks and KNIME workflows for teaching cheminformatics concepts. The 15 most recent publications reflect a strong trend toward integrating machine learning and deep learning (e.g., transformers, graph neural networks) with structure-based methods such as molecular docking, free energy calculations, and binding site comparison. Her work increasingly addresses real-world challenges in drug discovery, including kinase mutation resistance, selectivity optimization, and in vivo toxicity prediction using conformal and hybrid models. Scientific Contributions and Awards: Development of key computational tools: DoGSite, KiSSim, KinFragLib, TeachOpenCADD. Leadership in open-source and open-education initiatives in cheminformatics. Active publication record in top-tier journals with interdisciplinary impact. Advising and Grants: While specific student names and grant details are not mentioned in the provided text, her role as a corresponding author on numerous publications and the existence of a dedicated research lab ('volkamerlab') imply that she mentors students and postdoctoral researchers. She likely secures competitive funding to support her research in computational drug discovery and method development. Labs and Teams: She leads the Volkamer Lab ('volkamerlab'), which focuses on developing and applying computational methods for drug discovery. The lab collaborates with both academic and pharmaceutical partners and emphasizes open-source software development and educational outreach.

Christer B. Aakeröyمشاهده پروفایل

استاد

• Crystal Engineering
• Supramolecular Chemistry
• Pharmaceutical Solid-State Chemistry
• +۵ مورد دیگر

Professor Christer B. Aakeröy is the Taylor Chair University Distinguished Professor in the Department of Chemistry at Kansas State University. He has served as Head of the Department and has been at K-State since 1996. His research focuses on crystal engineering, supramolecular chemistry, and pharmaceutical solid-state properties. M.Sc., Uppsala University, Sweden (1985) D.Phil., University of Sussex, UK (1990) Dr. Aakeröy’s research explores non-covalent interactions in crystal engineering to design functional solid-state materials. His work leverages hydrogen and halogen bonding to assemble APIs into co-crystals, enhancing solubility and stability for pharmaceutical applications. He also investigates supramolecular architectures for nonlinear optical materials and mechanochemical synthesis methods. Recent publications highlight his focus on halogen bond donor preferences, chalcogen bonding, and computational tools for co-crystal design. His group’s work spans from fundamental crystal engineering to applied pharmaceutical solutions. Higuchi Award (2016) British Crystallographic Association Prize Lecture (2016) Presidential Award for Outstanding Undergraduate Teaching (2011) Making a Difference Award (2006) Segebrecht Distinguished Faculty Achievement Award (2003) His research group includes graduate and undergraduate researchers, and he has contributed to international scientific boards, including the Cambridge Crystallographic Data Centre. Collaborations, such as with Dr. Silvia Giordani, explore photochromic spiropyrans for chemosensory devices.

Evangelia Georgia Kostakiمشاهده پروفایل

مدرس

• Epidemiology
• Molecular Epidemiology
• HIV/AIDS Research
• +۷ مورد دیگر

Evangelia Georgia Kostaki is a Biostatistician and Epidemiologist serving as a Lecturer in the Department of Hygiene, Epidemiology, and Medical Statistics at the School of Medicine, National and Kapodistrian University of Athens (NKUA). She holds a PhD in Molecular Epidemiology from NKUA and has extensive teaching experience in medical statistics, epidemiology, and public health at the undergraduate and postgraduate levels. Her research focuses on molecular epidemiology of infectious diseases (HIV, HCV, HBV, and SARS-CoV-2), with emphasis on public health applications such as outbreak response and transmission network analysis. Education: Bachelor’s degree (NKUA) MSc in Biostatistics (NKUA) PhD in Molecular Epidemiology (NKUA) Research interests include HIV transmission dynamics, antiretroviral resistance surveillance, and pandemic response strategies. She has contributed to over 50 peer-reviewed articles and 2 book chapters, with active participation in global initiatives like the European AIDS Clinical Society (EACS) YING network and the Greek National Action Plan for HIV. Notable achievements include a New Investigator Scholarship (NSRF 2014-2020) and over 160 conference presentations internationally. Advisory roles include supervising 25+ MSc theses and supporting PhD candidates. Grants include co-investigator roles in national/international projects. She actively contributes to scientific societies, editorial boards, and guideline development for HIV testing protocols in Europe. Labs/Teams: Collaborates with the European Virus Bioinformatics Center (EVBC) and global networks addressing HIV and viral hepatitis epidemiology.

Gerhard Wolberمشاهده پروفایل

استاد

• Computational Drug Design
• G-Protein Coupled Receptors (GPCRs)
• Cytochrome P450 Enzymes
• +۳ مورد دیگر

Professor Gerhard Wolber leads the Molecular Drug Design research group at the Institute of Pharmacy , Freie Universitaet Berlin. His work focuses on computational approaches to drug discovery, with expertise in G-protein coupled receptors (GPCRs) , cytochrome P450 enzymes , Toll-like receptors , and viral protease inhibitors . He supervises a team of 13 PhD candidates 3 researchers 2 Master's students engaged in projects ranging from calcium channel blockers to CYP enzyme modulators for cancer therapy. Recent publications highlight his lab's contributions to pan-coronavirus drug discovery, TLR8 antagonism, and calcium channel inhibition. The team employs advanced methodologies including Molecular dynamics simulations Fragment-based de novo design Bayesian neural networks DFT calculations 3D pharmacophore modeling to bridge computational predictions with experimental validation. Notable projects include Virtual screening for TREM2-targeted glioblastoma therapeutics Allosteric communication path analysis via MDPath Immune checkpoint inhibitors for cancer immunotherapy Biased GPCR ligand development demonstrating a multidisciplinary approach to contemporary drug design challenges.

Arieh Warshelمشاهده پروفایل

استاد

• Theoretical Chemistry
• Biophysics
• Enzyme Catalysis
• +۷ مورد دیگر

Arieh Warshel is a Distinguished Professor of Chemistry and Biochemistry at the University of Southern California’s Dornsife College of Letters, Arts and Sciences. He holds the Dana and David Dornsife Chair in Chemistry and is a Nobel Laureate in Chemistry (2013) for pioneering multiscale simulation methods for biological molecules. His work integrates quantum mechanics and molecular mechanics (QM/MM) to model enzymatic reactions and biological processes. Warshel earned a B.S. from the Technion in Israel (1966), M.S. and Ph.D. from the Weizmann Institute (1967, 1969). He joined USC in 1976 and has since led groundbreaking research in theoretical chemistry, including studies of enzyme catalysis, molecular motors, ion channels, and drug design. His research focuses on computational modeling of biological systems, emphasizing electrostatic effects, proton/electron transfer, and protein dynamics. Key contributions include the EVB (Empirical Valence Bond) method and the QM/MM approach, which revolutionized simulations of enzymatic reactions. Current projects involve multiscale modeling of G-proteins, ion pumps, and molecular machines. Warshel has authored over 500 publications, including seminal works on enzyme catalysis, electrostatic interactions, and molecular dynamics. His honors include membership in the U.S. National Academy of Sciences, the Royal Society of Chemistry’s Honorary Fellowship, and the Biophysical Society’s Founders Award. He oversees a research group with expertise in computational chemistry, mentoring postdocs like Ashim Nandi (plastic-degrading enzymes) and graduate students (e.g., Aoxuan Zhang, Lingfeng Hu). His lab uses advanced computing resources, including 38 dedicated nodes on USC’s HPC cluster, to simulate biological systems at unprecedented scales.

• Pharmacology
• Molecular Biophysics
• Biochemistry
• +۸ مورد دیگر

Karen S. Anderson is a Professor of Pharmacology and Molecular Biophysics and Biochemistry at Yale School of Medicine, with a primary appointment in the Department of Pharmacology. She serves as Co-Leader of Developmental Therapeutics at Yale Cancer Center and Co-Director of the Therapeutics/Chemotherapy Program. Dr. Anderson is also an undergraduate research mentor and fellow at Pierson College at Yale, where she advises freshman students. Dr. Anderson's research program focuses on mechanistic enzymology and structure-based drug design to develop novel therapeutics. Her work centers on understanding molecular mechanisms of enzymes that play critical roles in cancer and infectious diseases, including HIV/AIDS. She has made significant contributions to the understanding of HIV reverse transcriptase, anticancer targets like EGFR and HER-2, and enzymes involved in parasitic infections. Her laboratory employs a multidisciplinary approach combining biophysical techniques, structural studies, and computational methods to advance drug discovery. Analysis of her recent publications (2023-2025) reveals a strong research trajectory spanning three main areas: HIV drug resistance and novel inhibitors, cancer therapeutics focusing on resistance mechanisms and targeted therapies, and antiviral/antimicrobial drug development including work on SARS-CoV-2. Her research demonstrates consistent innovation in structure-based drug design approaches across multiple disease areas. Selected Awards and Honors: Enzymes, Coenzymes, & Metabolic Pathways Gordon Research Conference Chair (2001) Yale Cancer Breast Cancer Initiative Research Award (1996) Dean's Young Faculty Award from Yale University (1991) Multiple Monsanto Research Achievement Awards (1985-1989) YWCA Women's Leadership Award (1986-1987) Dr. Anderson has trained over 50 undergraduates, graduate students, M.D./Ph.D. students and postdoctoral fellows who have gone on to successful careers in academia and industry. Her laboratory, the Anderson Lab, focuses on translating mechanistic and structural studies into novel therapeutic approaches for viral infections and cancer. The lab utilizes a range of biophysical techniques to study clinically relevant proteins with the goal of developing more effective therapies for conditions including cancer, infectious diseases, and neurodegenerative disorders.

John K. Walkerمشاهده پروفایل

دانشیار

• Medicinal Chemistry
• Synthetic Organic Chemistry
• Pharmacokinetics
• +۳ مورد دیگر

John K. Walker is an Associate Professor in the Department of Chemistry at Saint Louis University's School of Science and Engineering, with research affiliations in Pharmacology & Physiology. His work focuses on medicinal chemistry approaches to develop novel bioactive molecules targeting critical biological challenges. B.S. in Chemistry, Southern Illinois University at Edwardsville (1990) M.S. in Chemistry, Southern Illinois University at Edwardsville (1992) Ph.D. in Chemistry, Indiana University (1997) Research in the Walker Lab centers on medicinal chemistry , synthetic organic chemistry , and chemical biology , with particular emphasis on: Designing and synthesizing novel bioactive molecules Computational methods including molecular modeling and docking Bacterial efflux pump inhibitors to combat antibiotic resistance GPCR modulators for pain signaling pathways Development of tool compounds for biological studies Recent publications highlight his work in: Efflux pump inhibition mechanisms (2024-2025) Nuclear receptor agonist development (2024) GPCR signaling in pain pathways (2025) Antibiotic permeation modeling (2024) Metabolic disease therapeutics (2023-2024)

Lasse Heikkinenمشاهده پروفایل

مدرس ارشد

• Physics
• Applied Physics
• Process Tomography
• +۵ مورد دیگر

Lasse Heikkinen is a Senior Lecturer at the Department of Technical Physics, Faculty of Science, Forestry and Technology, University of Eastern Finland. His work spans applied physics, process tomography, and educational technology, with a focus on innovative teaching methods like flipped classrooms during the pandemic. Current Role: Deputy Head of Department, Senior University Lecturer Research Themes: Electrical impedance tomography for industrial processes, flipped teaching frameworks, and physics education adaptation to remote learning. Recent publications highlight his dual expertise in process tomography (gas-solid flows, pharmaceutical monitoring) and pedagogical innovation (learning analytics, flipped classrooms). He has contributed to educational manuals and toolkits for teacher training. Key Projects: Technology education infrastructure development (2015–2024), pandemic-era teaching adjustments (2022). Collaborations: Active in international process tomography conferences and multidisciplinary teams like the Ameba project.

Gabriele Romanoمشاهده پروفایل

استادیار

• Cancer drug resistance
• Tumor suppressor genes
• Immune evasion
• +۵ مورد دیگر

Gabriele Romano, PhD, is an Assistant Professor in the Department of Pharmacology & Physiology at Drexel University College of Medicine. His research focuses on cancer drug resistance mechanisms, leveraging mouse modeling, functional genomics, and computational biology. He leads the Romano Lab, which explores tumor-stroma interactions in minimal residual disease, tumor suppressor roles in therapy resistance, and HIV-cancer comorbidity. Education: PhD - Molecular and Translational Medicine, University of Milan, Bicocca (2015) MS - Medical Biotechnology, University of Milan, Bicocca (2012) BS - Biotechnology, University of Milan, Bicocca (2010) Research Interests: Cancer drug resistance mechanisms Immune evasion and tumor microenvironment Therapeutic strategies for HIV-associated cancers Functional genomics and nanoparticle delivery His work emphasizes developing novel therapies targeting residual tumor cells and improving outcomes for immunocompromised cancer patients. Key Awards: 2023 WW Smith Trust nominee (Cancer Research) 2022 Pew Biomedical Scholars competition nominee 2019 Maryanne Rosenstein Family Fellowship in Cancer Research Grants & Collaborations: Recipient of multiple institutional and foundation grants Collaborations with global institutions on translational projects Focus on mouse models, CRISPR screens, and bioinformatics Labs & Teams: Romano Lab at Drexel University Partnerships with MD Anderson Cancer Center and The Jackson Lab

Holly Goleckiمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Device Design
• Soft Robotics
• +۳ مورد دیگر

Holly Golecki is a Professor in the Department of Bioengineering at the University of Illinois at Urbana-Champaign (UIUC), affiliated with the Grainger College of Engineering. Her research focuses on the interface of humans and materials in medical devices and engineering education, emphasizing biomaterials in robotic systems, medical device design, and experiential learning. She leads initiatives such as the SIIP & Share Podcast , aimed at disseminating education innovations in engineering, and mentors programs like the UIUC First Gen Scholars Research Program. Her educational background includes contributions to bioengineering curriculum development, including courses on soft robotics and neural organoid biofabrication. She has secured funding through NSF grants, including the SCI-LSAMP project and the Jump Arches Program for wheelchair seat cushion development. Her work bridges research and practice, with a focus on increasing STEM participation through outreach and inclusive pedagogy. Golecki’s research group explores topics such as neural organoid engineering, soft robotics for medical applications, and adaptive scaffolding in capstone design. Collaborations include partnerships with institutions like Harvard Biodesign Lab and Sandia National Labs. Her lab activities include projects on biofabrication, tissue engineering, and robotics-enabled solutions for healthcare challenges. Notable contributions include over 20 peer-reviewed articles, conference presentations, and educational modules. She actively mentors students, supporting their transition to graduate programs and fostering interdisciplinary teamwork. Her efforts in grant acquisition and program leadership highlight her commitment to advancing both academic and practical contributions to biomedical engineering.

Bartosz Grzybowskiمشاهده پروفایل

استاد مدعو

• Artificial Intelligence in Chemistry
• Computer-Assisted Organic Synthesis
• Reaction Network Analysis
• +۳ مورد دیگر

Bartosz Grzybowski serves as Distinguished Affiliate Professor at the Institute of Organic Chemistry, Polish Academy of Sciences (PAS), leading the Laboratory of Computer-Assisted Synthesis. His work bridges artificial intelligence and experimental organic chemistry to transform synthesis from trial-and-error into algorithmic science. His research focuses on AI-driven synthesis planning , reaction network analysis , and computational prediction of chemical properties . Key contributions include pioneering algorithms for multistep organic synthesis of complex targets, discovery of novel organic reactions through AI, and design of temporally/spatially synchronized reaction networks. His group develops methods for sustainable chemistry, drug analog design, and enzymatic process optimization. Analysis of his 2023-2025 publications reveals dominant trends in retrosynthetic AI (87% of articles), sustainable chemistry applications (63%), and integration of mechanistic understanding with machine learning. Work frequently appears in Nature , Science , and JACS , emphasizing experimental validation of computational predictions. Prof. Grzybowski currently advises three PhD students and collaborates with a multidisciplinary team: Core team : Assoc. Prof. Michał Michalak (Adjunct), Dr. Anna Żądło-Dobrowolska, Dr. Aleksei Koshevarnikov Active grant : NCN SONATA 2020/39/D/ST4/01890 on hazardous chemical degradation (PI: Żądło-Dobrowolska) The Laboratory of Computer-Assisted Synthesis operates as an integrated computational-experimental unit at IBS-IOC PAS. Current projects include blockchain-orchestrated reaction networks, AI-guided catalyst selection, and metabolic-cycle emulation. The group maintains strong industry/academic partnerships for validating algorithms in drug discovery and green chemistry applications.

Gaurav Aryaمشاهده پروفایل

استاد

• Viral DNA Packaging
• Polymer-Nanoparticle Composites
• Virus Assembly
• +۷ مورد دیگر

Gaurav Arya is a Professor in the Thomas Lord Department of Mechanical Engineering and Materials Science at Duke University, with additional appointments in the Department of Chemistry and Biomedical Engineering. His research laboratory employs physics-based computational tools to investigate biological and soft-material systems at the molecular scale. Ph.D. from University of Notre Dame (2003) B.Tech. from Indian Institute of Technology Delhi (1998) Research focuses on: Molecular modeling and simulations Statistical mechanics DNA nanotechnology Viral DNA packaging Chromatin biophysics Polymer-nanoparticle composites Recent research trends emphasize AI-driven materials discovery and programmable DNA nanostructures. Key grants include: NSF DMREF: Architecting DNA nanodevices (2023-2027) DOE Mesoscale Self-Assembly (2020-2027) UC San Diego Ligand-Nanocrystal Interlayer Studies (2024-2027) Scientific contributions: Featured in 2025 Nature Communications on DNA superstructures 2022 Science Advances on DNA nanodevice reconfiguration 2021 PNAS on viral DNA packaging motors

Philippe Cinquinمشاهده پروفایل

استاد

• Computer-Assisted Medical Interventions (CAMI)
• Medical Robotics
• Biomimetic Medical Devices
• +۴ مورد دیگر

Philippe Cinquin is a Professor of Medical Informatics and Director of TIMC-IMAG (UMR5525), a CNRS-Université Joseph Fourier research unit. He leads the CAMI (Computer Assisted Medical Interventions) Labex and co-heads INSERM's CIC-IT 803 clinical investigation center. With a PhD in Applied Mathematics and Medical Doctor qualification, he pioneered surgical robotics and computer-aided interventions since 1984, benefiting over 100,000 patients through startup innovations. His recent work focuses on symbiotic implantable devices, energy scavenging for medical implants, and hydrogen therapy. He received the 2013 CNRS Innovation Award and 2014 Ambroise Paré Surgical Award. Research interests span biomimetic devices, medical robotics, and innovative therapies including transdermal hydrogen delivery. He has developed implantable systems like intestinal reactors and biosensors, with applications in diabetes treatment and pandemic response. His work integrates mathematics, signal processing, and nanotechnology to advance minimally invasive surgery and autonomous medical implants. Key contributions include virtual fluoroscopy systems for navigation, enzymatic biofuel cells, and reusable PPE sterilization methods during the pandemic. His interdisciplinary teams collaborate across engineering, medicine, and computer science to address clinical challenges through technological innovation. Education: PhD in Applied Mathematics; Medical Doctorate Grants & Startups: Founded multiple companies commercializing surgical navigation systems and diagnostic devices Labs: TIMC-IMAG, CAMI Labex, CIC-IT 803 clinical innovation center

Aydin K. Sunolمشاهده پروفایل

استاد

• Green Engineering
• Supercritical Fluid Technology
• Systems Engineering
• +۷ مورد دیگر

Dr. Aydin K. Sunol is a Professor of Chemical, Biological and Materials Engineering at the University of South Florida's College of Engineering. With a distinguished career spanning several decades, he leads the Environmentally Friendly Engineered Systems (EFES) Lab and serves as principal investigator for numerous research projects funded by NASA, DOD, NSF, and industry partners. Education: PhD in Chemical Engineering, VPI & SU, Blacksburg, Virginia MEng in Industrial Engineering and Operational Research, VPI & SU, Blacksburg, Virginia Diploma in Chemical Engineering, University of Aston, Birmingham, England BS in Chemical Engineering, Bogazici University, Istanbul, Turkey Dr. Sunol's research focuses on green engineering and chemistry, sustainability in the chemical industry, systems engineering, and cleaner energy conversion processes. His work integrates global computational methods, machine learning, product prototyping, and experimentation across multiple temporal and spatial scales. Recent projects include developing nano-structured photo-catalysts, therapeutic particles, and energetic materials using environmentally friendly pathways, as well as creating efficient fuel conversion processes utilizing supercritical fluids. His research demonstrates a consistent trend toward sustainable solutions that address fundamental challenges in materials science, energy conversion, and environmental protection through innovative application of supercritical fluid technology and computational methods. Scientific Awards: USF Chemical and Biomedical Engineering Department Outstanding Teaching Award, 2018 University of South Florida Outstanding Undergraduate Teaching Award, 2002-2003 Engineering Professor of the Year, 1984 Outstanding Professor of Chemical Engineering, VPI & SU, 1981 Outstanding Technology Innovation Award, Aerospace Space System Conference, 2010 As an educator, Dr. Sunol has advised 18 PhD and 29 Master's students, developing innovative teaching methods and curricula including NSF-funded Web-based Teaching Modules and Design Course Series. His research has been supported by diverse funding sources including DOE, NSF, NATO, UNESCO, NAVY, NASA, and numerous industry partners. Dr. Sunol also serves as principal partner and CTO of Temptroll LLC and Accent Creations LLC, which develop self-heating and cooling products, demonstrating the practical application of his research. The EFES Lab, which Dr. Sunol directs, brings together interdisciplinary researchers including chemical engineers, mechanical engineers, and computer scientists to tackle complex challenges in sustainable engineering. Current team members include PhD candidates working on nano-structured materials, wastewater management systems, and temperature modulation products, continuing the lab's tradition of innovation in environmentally friendly engineered systems.